These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37913954)

  • 21. In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy.
    Alongi F; Arcangeli S; Cuccia F; D'Angelillo RM; Di Muzio NG; Filippi AR; Jereczek-Fossa BA; Livi L; Pergolizzi S; Scorsetti M; Corvò R; Magrini SM
    Radiother Oncol; 2021 Feb; 155():e20-e21. PubMed ID: 33387582
    [No Abstract]   [Full Text] [Related]  

  • 22. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
    McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
    Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating large language models on a highly-specialized topic, radiation oncology physics.
    Holmes J; Liu Z; Zhang L; Ding Y; Sio TT; McGee LA; Ashman JB; Li X; Liu T; Shen J; Liu W
    Front Oncol; 2023; 13():1219326. PubMed ID: 37529688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.
    Kitamura K; Shirato H; Shinohara N; Harabayashi T; Onimaru R; Fujita K; Shimizu S; Nonomura K; Koyanagi T; Miyasaka K
    Cancer J; 2003; 9(4):268-76. PubMed ID: 12967137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on "Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus." Kalakota K, Liauw SL, Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL.: Urology 2013;81(6):1196-201. doi: 10.1016/j.urology.2013.01.047. [Epub 2013 Mar 26].
    Gottschalk A
    Urol Oncol; 2014 Apr; 32(3):374. PubMed ID: 24679464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
    J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy.
    Jereczek-Fossa BA; Ciardo D; Ferrario S; Fossati P; Fanetti G; Zerini D; Zannoni D; Fodor C; Gerardi MA; Surgo A; Muto M; Cambria R; De Cobelli O; Orecchia R
    Br J Radiol; 2016 Jul; 89(1063):20150985. PubMed ID: 27109736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
    Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
    Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Evaluation of Aeyeconsult: A Novel Ophthalmology Chatbot Leveraging Verified Textbook Knowledge and GPT-4.
    Singer MB; Fu JJ; Chow J; Teng CC
    J Surg Educ; 2024 Mar; 81(3):438-443. PubMed ID: 38135548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
    Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
    JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A solid water pelvic and prostate phantom for imaging, volume rendering, treatment planning, and dosimetry for an RTOG multi-institutional, 3-D dose escalation study. Radiation Therapy Oncology Group.
    Paliwal BR; Ritter MA; McNutt TR; Mackie TR; Thomadsen BR; Purdy JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):205-11. PubMed ID: 9747839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?
    Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered.
    Showalter TN; Wages NA; Ohri N
    Cancer Biol Ther; 2014 Apr; 15(4):361-4. PubMed ID: 24521697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
    Schilling PJ
    Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the "Hostile Pelvis" for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy.
    Yirmibeşoğlu Erkal E; Karabey S; Karabey A; Hayran M; Erkal HŞ
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):894-903. PubMed ID: 26104941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
    Michalski JM; Roach M; Merrick G; Anscher MS; Beyer DC; Lawton CA; Lee WR; Pollack A; Rosenthal SA; Vijayakumar S; Carroll PR
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):667-72. PubMed ID: 19386445
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
    Eade TN; Horwitz EM; Ruth K; Buyyounouski MK; D'Ambrosio DJ; Feigenberg SJ; Chen DY; Pollack A
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):338-45. PubMed ID: 18207665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the Patterns of Care process survey between 1996-1998 and 1999-2001.
    Ogawa K; Nakamura K; Sasaki T; Yamamoto T; Koizumi M; Inoue T; Teshima T;
    Jpn J Clin Oncol; 2004 Mar; 34(3):131-6. PubMed ID: 15078908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.